RecruitingNCT05747365

Role of Endocrine Disruptors in Thyroid Cancer

Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer


Sponsor

Istituto Auxologico Italiano

Enrollment

222 participants

Start Date

Jul 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

the relationship between human exposure to EDCS and TC is poorly investigated and still unclear. The aim of this study is to evaluate the possible role of old and new generation endocrine disruptors in thyroid cancer. The primary aim is to evaluate the difference in the average levels of the main endocrine disruptors (PFAS, including: PFOA, PFOS, PFDA, PFUnA, PFHpS and possibly subsequently other categories, such as bisphenols, phthalates, parabens, PCBs, flame retardants) between patients with and without a diagnosis of thyroid cancer through highly sensitive, selective and precise mass spectrometry methods, such as liquid chromatography combined with tandem mass spectrometry (LC-MS / MS). The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied (for example the type of diet, the use of personal care products).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether exposure to endocrine-disrupting chemicals (substances found in plastics, pesticides, and other everyday products that can interfere with hormones) is linked to the development of thyroid cancer. **You may be eligible if...** - You have been diagnosed with thyroid cancer in the last 5 years (study arm A), OR - You do not have thyroid cancer and are being enrolled to be matched with someone who does (control group) - You are 18 or older **You may NOT be eligible if...** - You are under 18 years old - You are unable to sign informed consent forms or complete questionnaires Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood and urine diagnostic evaluation

Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations


Locations(1)

Istituto Auxologico Italiano, IRCCS

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05747365


Related Trials